Cognitive dysfunction in FMR1 premutation carriers

Current Psychiatry Reviews

Volumn 9, Issue 1, 2013, Pages 78-84

  Seritan, Andreea ^a,b   Cogswell, Jennifer ^b   Grigsby, Jim ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Cognition; Dementia; Executive function; FMR1 premutation; FXTAS; Memory

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN;

APRAXIA; ARTICLE; COGNITIVE DEFECT; DEMENTIA; DIFFERENTIAL DIAGNOSIS; GENE MUTATION; GENETIC RISK; HETEROZYGOTE; HUMAN; MENTAL DISEASE; NEUROPSYCHIATRY; PERSONALITY DISORDER; PRIORITY JOURNAL;

EID: 84875312134     PISSN: 15734005     EISSN: 18756441     Source Type: Journal    
DOI: 10.2174/157340013805289635     Document Type: Article

References (75)

1. Hagerman RJ, Leehey M, Heinrichs W, et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 2001; 57: 127-30.
2. Jacquemont S, Hagerman RJ, Leehey M, et al. Fragile X premutation tremor/ataxia syndrome: Molecular, clinical, and neuroimaging correlates. Am J Hum Genet 2003; 72: 869-78.
3. Hagerman PJ. The fragile X prevalence paradox. J Med Genet 2008; 45: 498-9.
4. Tassone F, Hagerman RJ, Taylor AK, Gane LW, Godfrey TE, Hagerman PJ. Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in fragile X syndrome. Am J Hum Genet 2000; 66: 6-15.
5. Greco C, Berman RF, Martin RM, et al. Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain 2006; 129: 243-55.
6. Jacquemont S, Hagerman RJ, Leehey MA, et al. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA 2004; 291: 460-9.
7. Hagerman PJ, Hagerman RJ. Fragile X-associated tremor/ataxia syndrome (FXTAS). Ment Retard Dev Disabil Res Rev 2004; 10: 25-30.
8. Coffey SM, Cook K, Tartaglia N, et al. Expanded clinical phenotype of women with the FMR1 premutation. Am J Med Genet 2008; 146A: 1009-16.
9. Rodriguez-Revenga L, Madrigal I, Pagonabarraga J, et al. Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families. Eur J Hum Genet 2009; 17: 1359-62.
10. Jacquemont S, Farzin F, Hall D, et al. Aging in individuals with the FMR1 mutation. Am J Ment Retard 2004; 09: 154-64.
11. Leehey MA, Berry-Kravis E, Min SJ, et al. Progression of tremor and ataxia in male carriers of the FMR1 premutation. Mov Disord 2007; 22: 203-6.
12. Bacalman S, Farzin F, Bourgeois JA, et al. Psychiatric phenotype of the fragile X-associated tremor/ataxia syndrome (FXTAS) in males: newly described fronto-subcortical dementia. J Clin Psychiatry 2006; 67:87-94.
13. Seritan AL, Nguyen DV, Farias ST, et al. Dementia in fragile Xassociated tremor/ataxia syndrome (FXTAS): Comparison with Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 2008; 147B:1138-44.
14. Brega AG, Reynolds A, Bennett RE, et al. Functional status of men with the fragile X premutation, with and without the tremor/ataxia syndrome (FXTAS). Int J Geriatr Psychiatry 2009; 24: 1101-9.
15. Moore CJ, Daly EM, Schmitz N, et al. A neuropsychological investigation of male premutation carriers of fragile X syndrome. Neuropsychologia 2004; 42: 1934-47.
16. Grigsby J, Brega AG, Jacquemont S, et al. Impairment in the cognitive functioning of men with fragile X tremor-ataxia syndrome (FXTAS). J Neurol Sci 2006; 248: 227-33.
17. Grigsby J, Leehey MA, Jacquemont S, et al. Cognitive impairment in a 65-year-old male with the fragile X- associated tremor-ataxia syndrome (FXTAS). Cogn Behav Neurol 2006; 19: 165-71.
18. Grigsby J, Brega AG, Leehey MA, et al. Impairment of executive cognitive functioning in males with fragile X-associated tremor/ataxia syndrome. Mov Disord 2007; 22: 645-50.
19. Grigsby J, Brega AG, Engle K, et al. Cognitive profile of fragile X premutation carriers with and without fragile X-associated tremor/ ataxia syndrome. Neuropsychology 2008; 22: 48-60.
20. Cornish KM, Li L, Kogan CS, et al. Age-dependent cognitive changes in carriers of the fragile X syndrome. Cortex 2008; 44: 628-36.
21. Cornish KM, Kogan C, Li L, Turk J, Jacquemont S, Hagerman RJ. Lifespan changes in working memory in fragile X premutation males. Brain Cogn 2009; 69: 551-8.
22. Kogan CS, Turk J, Hagerman RJ, et al. Impact of the fragile X mental retardation 1 (FMR1) gene premutation on neuropsychiatric functioning in adult males without fragile X-associated tremor/ ataxia syndrome: a controlled study. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 859-72.
23. Allen EG, Hunter JE, Rusin M, et al. Neuropsychological findings from older premutation carriers and their noncarrier siblings form families with fragile X syndrome. Neuropsychology 2011; 25: 4040-11.
24. Hunter JE, Sherman S, Grigsby J, Kogan C, Cornish K. Capturing the fragile X premutation phenotypes: a collaborative effort across multiple cohorts. Neuropsychology 2012; 26: 156-164.
25. Brega AG, Goodrich G, Bennett RE, et al. The primary cognitive deficit among males with fragile X-associated tremor/ataxia syndrome (FXTAS) is a dysexecutive syndrome. J Clin Exp Neuropsychol 2008; 30: 853-69.
26. Goodrich-Hunsaker NJ, Wong L, McLennan Y, et al. Young adult female fragile X premutation carriers show age- and geneticallymodulated cognitive impairments. Brain Cogn 2011; 75: 255-60.
27. Cornish KM, Hocking DR, Moss SA, Kogan CS. Selective executive markers of at-risk profiles associated with the fragile X premutation. Neurology 2011; 77: 618-22.
28. Minguez M, Ibanez B, Ribate MP, et al. Risk of cognitive impairment in female premutation carriwes of fragile X premutation: analysis by means of robust segmented linear regression models. Am J Med Genet B Neuropsychiatr Genet 2009; 150B: 262-70.
29. Hunter JE, Rohr JK, Sherman SL. Co-occurring diagnoses among FMR1 premutation allele carriers. Clin Genet 2010; 77: 374-81.
30. Lachiewicz AM, Dawson DV, Spiridigliozzi GA, McConkie- Rosell A. Arithmetic difficulties in females with the fragile X premutation. Am J Med Genet 2006; 140A: 665-72.
31. Sevin M, Kutalik Z, Bergman S, et al. Penetrance of marked cognitive impairment in older male carriers of the FMR1 gene premutation. J Med Genet 2009; 46: 818-24.
32. Gane LW, Iosif AM, Flynn-Wilson L, Venturino M, Hagerman RJ, Seritan AL. Assessment of patient and caregiver needs in fragile Xassociated tremor/ataxia syndrome (FXTAS) by utilizing Q-sort methodology. Aging Ment Health 2010; 14: 1000-7.
33. Mothersead PK, Conrad K, Hagerman RJ, Greco CM, Hessl D, Tassone F. An atypical progressive dementia in a male carrier of the fragile X premutation: An example of fragile X-associated tremor/ataxia syndrome. Appl Neuropsychol 2005; 12: 169-78.
34. Bourgeois JB, Farzin F, Brunberg JA, et al. Dementia with mood symptoms in a carrier of the fragile X-associated tremor/ ataxia syndrome (FXTAS): Clinical intervention with donepezil and venalafaxine. J Neuropsychiatry Clin Neurosci 2006; 18: 171-7.
35. Bourgeois JA, Cogswell JB, Hessl D, et al. Cognitive, anxiety and mood disorders in the fragile X-associated tremor/ataxia syndrome. Gen Hosp Psychiatry 2007; 29: 349-56.
36. Al-Hinti JT, Nagan N, Harik SI. Fragile X premutation in a woman with cognitive impairment, tremor, and history of premature ovarian failure. Alzheimer Dis Assoc Disord 2007; 21: 262-4.
37. Gonçalves MR, Capelli LP, Nitrini R, et al. Atypical course of FXTAS: rapidly progressive dementia as the major symptom. Neurology 2007; 68: 1864-6.
38. Jenkins EC, Tassone F, Ye L, et al. Reduced telomere length in older men with premutation alleles of the fragile X mental retardation 1 gene. Am J Med Genet 2008; 146A: 1543-6.
39. Karmon Y, Gadoth N. Fragile X associated tremor/ataxia syndrome (FXTAS) with dementia in a female harbouring FMR1 premutation. J Neurol Neurosurg Psychiatry 2008; 79: 738-9.
40. Yachnis AT, Roth HL, Heilman KM. Fragile X dementia parkinsonism syndrome (FXDPS). Cogn Behav Neurol 2010; 23: 39-43.
41. Rodriguez-Revenga L, Pagonabarraga J, Gomez-Anson B, et al. Motor and mental dysfunction in mother-daughter transmitted FXTAS. Neurology 2010; 75: 1370-6.
42. National Alzheimer's Coordinating Center. Uniform Data Set Coding Guidebook. Seattle: NACC, 2006.
43. American Psychiatric Association. Diagnostic Criteria from DSMIV- TR. Washington, DC: American Psychiatric Press, Inc., 2000; p. 94.
44. Tassone F, Greco CM, Hunsaker M, et al. Neuropathological, clinical, and molecular pathology in female fragile X premutation carriers with and without FXTAS. Genes Brain Behav 2012; 11: 577-85.
45. Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol 1993; 50: 873-990.
46. Seritan AL, Schneider A, Olichney JM, Leehey MA, Akins RS, Hagerman RJ. Conversion disorder in women with the FMR1 premutation. Am J Med Genet 2009; 149: 2501-6.
47. Schmahmann JD. Disorders of the cerebellum: Ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome. J Neuropsychiatry Clin Neurosci 2004; 16: 367-78.
48. Brunberg JA, Jacquemont S, Hagerman RJ, et al. Fragile X premutation carriers: Characteristic MR imaging findings in adult males with progressive cerebellar and cognitive dysfunction. Am J Neuroradiol 2002; 23: 1757-66.
49. Schmahmann JD, Smith EE, Eichler FS, Filley CM. Cerebral white matter. Neuroanatomy, clinical neurology, and neurobehavioral correlates. Ann NY Acad Sci 2008; 1142: 266-309.
50. Schmahmann JD, Pandya D. Disconnection syndromes of basal ganglia, thalamus, and cerebrocerebellar systems. Cortex 2008; 44: 1037-66.
51. Hashimoto R, Srivastava S, Tassone F, Hagerman RJ, Rivera SM. Diffusion tensor imaging in male premutation carriers of the fragile X mental retardation gene. Mov Disord 2011; 26: 1329-36.
52. de Carvalho MR, Dias GP, Cosci F, et al. Current findings in panic disorder: contributions for the fear neurocircuitry and CBT effects. Expert Rev Neurother 2010; 10: 291-303.
53. Hessl D, Rivera S, Koldewyn K, et al. Amygdala dysfunction in men with the fragile X premutation. Brain 2007; 130: 404-16.
54. Selmeczy D, Koldewyn K, Wang JM, et al. Investigation of amygdala volume in men with the fragile X premutation. Brain Imaging Behav 2011; 5: 285-94.
55. Hashimoto R, Javan AK, Tassone F, Hagerman RJ, Rivera SM. A voxel-based morphometry study of grey matter loss in fragile Xassociated tremor/ataxia syndrome. Brain 2011; 134: 863-78.
56. Adams PE, Adams JS, Nguyen DV, et al. Psychological symptoms correlate with reduced hippocampal volume in fragile X premutation carriers. Am J Med Genet Neuropsychiatr Genet 2010; 153B: 775-85.
57. Mendez MF, Cummings JL. Dementia: A Clinical Approach. Philadelphia: Butterworth Heinemann, 2003; pp. 67-76, 180-84, 236-8, 252-60, 291-301, 316-8.
58. Rabinovici GD, Miller BL. Frontotemporal lobar degeneration: Epidemiology, pathophysiology, diagnosis and management. CNS Drugs 2010; 24: 375-98.
59. Rana AQ, Yousuf MS, Naz S, Qa'aty N. Prevalence and relation of dementia to various factors in Parkinsons's disease. Psychiatry Clin Neurosci 2012; 66: 64-8.
60. Kurz MW, Schlitter AM, Klenk Y, et al. FMR1 alleles in Parkinson's disease: relation to cognitive decline and hallucinations, a longitudinal study. J Geriatr Psychiatry Neurol 2007; 20: 89-92.
61. Greco CM, Tassone F, Garcia-Arocena D, et al. Clinical and neuropathologic findings in a woman with the FMR1 premutation and multiple sclerosis. Arch Neurol 2008; 65: 1114-6.
62. Volicer L, McKee A, Hewitt S. Dementia. Neurol Clin 2001; 19: 867-85.
63. Wenning GL, Litvan I, Tolosa E. Milestones in atypical and secondary parkinsonisms. Mov Disord 2011; 26: 1083-95.
64. Seritan AL, Mendez MF, Silverman DHS, Hurley RA, Taber KH. Functional imaging as a window to dementia: Corticobasal degeneration. J Neuropsychiatry Clin Neurosci 2004; 16: 393-9.
65. Cummings JL, Litvan I. Neuropsychiatric aspects of corticobasal degeneration. Adv Neurol 2000; 82: 147-52.
66. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB international workshop. Neurology 1996; 47: 1113-24.
67. Adams SA, Steenblock KJ, Thibodeau SN, Lindor NM. Premutations in the FMR1 gene are uncommon in men undergoing genetic testing for spinocerebellar ataxia. J Neurogenet 2008; 22: 77-92.
68. Rottneck M, Riggio S, Byne W, Sano M, Margolis RL, Walker RH. Schizophrenia in a patient with spinocerebellar ataxia 2: coincidence of two disorders or a neurodegenerative disease presenting with psychosis? Am J Psychiatry 2008; 165: 964-7.
69. Wexler E, Fogel BL. New-onset psychosis in a patient with spinocerebellar ataxia type 10. Am J Psychiatry 2011; 168: 1339-40.
70. Seixas AI, Vale J, Jorge P, et al. FXTAS is rare among Portuguese patients with movement disorders: FMR1 premutations may be associated with a wider spectrum of phenotypes. Behav Brain Funct 2011; 7: 19.
71. Hall DA, Berry-Kravis E, Hagerman RJ, Hagerman PJ, Rice CD, Leehey MA. Symptomatic treatment in the fragile X-associated tremor/ataxia syndrome. Mov Disord 2006; 21: 1741-3.
72. Ortigas MC, Bourgeois JA, Schneider A, et al. Improving fragile X-associated tremor/ataxia syndrome symptoms with memantine and venlafaxine. J Clin Psychopharmacol 2010; 30: 642-4.
73. Ross-Inta CE, Omanska-Klusek A, Wong S et al. Evidence of mitochondrial dysfunction in fragile X-associated tremor/ataxia syndrome. Biochem J 2010; 429: 545-52.
74. Napoli E, Ross-Inta C, Wong S, et al. Altered zinc transport disrupts mitochondrial protein processing/import in fragile X-associated tremor/ataxia syndrome. Hum Mol Genet 2011; 20: 3079-92.
75. Leehey MA. Fragile X-associated tremor/ataxia syndrome: clinical phenotype, diagnosis, and treatment. J Investig Med 2009; 57: 830-6.